Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v8-FR
Language French French
Date Updated 2019-12-13 2019-12-13
Drug Identification Number 02452111 02452111
Brand name RAN-TADALAFIL RAN-TADALAFIL
Common or Proper name RAN-TADALAFIL RAN-TADALAFIL
Company Name RANBAXY PHARMACEUTICALS CANADA INC. RANBAXY PHARMACEUTICALS CANADA INC.
Ingredients TADALAFIL TADALAFIL
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 4 4
ATC code G04BE G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-25 2019-10-25
Estimated end date 2019-12-13 2019-12-13
Actual end date 2019-11-29 2019-11-29
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments